[Current diagnosis and clinical prognostic value of kidney dysfunction in patients with coronary heart disease]

Area of Science:

• Nephrology
• Cardiology
• Biomarker Discovery

Context:

• Kidney dysfunction significantly impacts outcomes in cardiac patients.
• Traditional cardiovascular risk factors are linked to kidney dysfunction.
• Early identification of kidney injury is crucial for managing cardiac patient prognosis.

Purpose:

• To evaluate cystatin C as a novel biomarker for early kidney injury detection.
• To assess the predictive value of cystatin C for renal failure (RF) risk in cardiac patients.
• To explore cystatin C's role in predicting the need for renal replacement therapy and mortality.

Summary:

• Cystatin C demonstrates potential as an ideal biomarker for identifying early kidney injury.
• It aids in assessing renal failure (RF) risk, guiding renal replacement therapy decisions, and predicting mortality in cardiac intensive care units.
• The study highlights the necessity of uniform management strategies for chronic kidney disease complications like anemia and phosphorus-calcium disorders.

Impact:

• Improved early prediction of renal failure (RF) in cardiac patients.
• Enhanced risk stratification for renal replacement therapy and mortality.
• Potential for optimized management of kidney dysfunction complications in diverse patient groups.